Micron Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-07-2024
- Paid Up Capital ₹ 0.50 M
as on 08-07-2024
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -98.59%
(FY 2022)
- Profit -98.53%
(FY 2022)
- Ebitda 97.84%
(FY 2022)
- Net Worth 0.87%
(FY 2022)
- Total Assets -15.89%
(FY 2022)
About Micron Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Naresh Jain, Pushpak Ranka, Mahesh Ranka, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PLC156473
- Company No.
156473
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Micron Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Jain  | Director | 30-Sep-2005 | Current |
| Pushpak Ranka | Director | 13-Jun-2016 | Current |
| Mahesh Ranka | Director | Current | |
| Vinod Ranka | Director | 13-Jun-2016 | Current |
Financial Performance of Micron Pharmaceuticals.
Micron Pharmaceuticals Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.59% decrease. The company also saw a substantial fall in profitability, with a 98.53% decrease in profit. The company's net worth moved up by a moderate rise of 0.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Micron Pharmaceuticals?
In 2021, Micron Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Micro Orgo Chem Private LimitedActive 13 years 5 monthsPushpak Ranka and Vinod Ranka are mutual person
Micron Medica Private LimitedActive 10 months 14 daysNaresh Jain and Pushpak Ranka are mutual person
- Winning Edge Sports Promotion Private LimitedActive 23 years 4 months
Naresh Jain is a mutual person
- Micro Housing And Infrastructure Private Limited.Active 17 years 5 months
Naresh Jain and Pushpak Ranka are mutual person
- Bhagyalaxmi Developers Private LimitedActive 26 years 9 months
Naresh Jain and Pushpak Ranka are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Micron Pharmaceuticals?
Unlock and access historical data on people associated with Micron Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Micron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Micron Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
